Home
August 2008 September 2008 October 2008
Su Mo Tu We Th Fr Sa
Week 36 1 2 3 4 5 6
Week 37 7 8 9 10 11 12 13
Week 38 14 15 16 17 18 19 20
Week 39 21 22 23 24 25 26 27
Week 40 28 29 30

Acute Testosterone Decrease Does Not Affect Mood in Most Healthy Men Show Comments PDF Print E-mail
Wednesday, 20 October 2004
NEW YORK (Reuters Health) - Pharmacologically induced reductions in testosterone do not appear to adversely affect mood in most healthy young men, according to a new report.

NEW YORK (Reuters Health) - Pharmacologically induced reductions in testosterone do not appear to adversely affect mood in most healthy young men, according to a new report.

"The effects of declining androgen secretion on mood regulation and the potential psychotropic efficacy of androgen replacement in men are largely undetermined," Dr. Peter J. Schmidt and colleagues from the National Institutes of Health, Bethesda, Maryland, write in the October issue of the Archives of General Psychiatry.

In a double-blind, placebo-controlled, crossover study, the researchers examined the effects on mood of the acute suppression of testosterone secretion in healthy men. A total of 31 men with no history of psychiatric illness or anabolic steroid abuse were included in the study.

The men received 7.5 mg intramuscular depot leuprolide acetate (Lupron) every 4 weeks for 3 months. After the first 4 weeks, the men were randomly assigned to receive, in addition to Lupron, 200 mg intramuscular testosterone enanthate or placebo every 2 weeks for 1 month each in a crossover design. Main outcome measures included mood and behavior rating scores.

Significant increases in hot flush severity and significant decreases in sexual interest and the feeling of being "emotionally charged" were observed during Lupron plus placebo phase compared with baseline and Lupron plus testosterone phase. However, no significant differences in sadness, anxiety, irritability, anhedonia or decreased energy were seen between the Lupron plus placebo and the Lupron plus testosterone groups.

The investigators did not observe a uniform effect of Lupron plus placebo on mood. However, three men experienced clinically significant mood symptoms during the artificially induced hypogonadal condition.

"Men with high baseline sexual interest had a significant decrease in sexual interest during Lupron plus placebo (p < 0.01), and levels of sexual interest were restored to baseline levels during Lupron plus testosterone," Dr. Schmidt and colleagues report.

"Overall, our data suggest that acute androgen withdrawal, while associated with decreased libido and hot flushes, is not sufficient to uniformly alter mood in healthy young adult men."

Arch Gen Psychiatry 2004;61:997-1004


Copyright © 2003 Reuters Limited. All rights reserved. Republication or redistribution of Reuters Limited content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters Limited. Reuters Limited shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Reader Comments

Please log-in or register in order to submit comments.

Powered by AkoComment!

 
User Rating: / 0
PoorBest


 
< Prev   Next >